JPMorgan weighs in on Neutral-rated Thoratec (THOR -4.5%) after the firm recalled its HeartMate...

|About: Thoratec Corporation (THOR)|By:, SA News Editor

JPMorgan weighs in on Neutral-rated Thoratec (THOR -4.5%) after the firm recalled its HeartMate device prompting a rapid-fire selloff. Analysts with JP call the action a "non-event" since the issue was related to the heart pump's implementation instructions rather than the device itself. Shares are now down 4.5% after spiraling 12.5% lower earlier.